Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Portage Biotech Inc. (PRTG : NSDQ)
 
 • Company Description   
Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Number of Employees: 7

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.66 Daily Weekly Monthly
20 Day Moving Average: 234,508 shares
Shares Outstanding: 1.05 (millions)
Market Capitalization: $5.94 (millions)
Beta: 0.23
52 Week High: $13.20
52 Week Low: $2.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -32.46% -36.12%
12 Week 10.98% -6.89%
Year To Date 9.48% 2.54%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
CLARENCE THOMAS BUILDING P.O. BOX 4649 ROAD TOWN
-
TORTOLA,D8 VG1110
-
ph: 203-221-7378
fax: -
cpadala@lifesciadvisors.com http://www.portagebiotech.com
 
 • General Corporate Information   
Officers
Ian Walters - Chairman and and Chief Executive Officer
Allan Shaw - Chief Financial Officer
Justin Fairchild - Vice President of Development
Gregory Bailey - Director
Steven Mintz - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: G7185A136
SIC: 2834
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 08/26/25
Share - Related Items
Shares Outstanding: 1.05
Most Recent Split Date: 8.00 (0.05:1)
Beta: 0.23
Market Capitalization: $5.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/26/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 0.70
Price / Sales: -
EPS Growth
vs. Year Ago Period: 78.28%
vs. Previous Quarter: 20.25%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©